Amdocs Limited (NASDAQ:DOX – Get Free Report) announced a quarterly dividend on Wednesday, May 13th. Shareholders of record on Tuesday, June 30th will be given a dividend of 0.569 per share by the technology company on Friday, July 31st. This represents a c) annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend is Tuesday, June 30th.
Amdocs has raised its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 14 consecutive years. Amdocs has a dividend payout ratio of 29.9% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Amdocs to earn $7.25 per share next year, which means the company should continue to be able to cover its $2.27 annual dividend with an expected future payout ratio of 31.3%.
Amdocs Price Performance
Amdocs stock opened at $51.97 on Friday. Amdocs has a 52 week low of $49.79 and a 52 week high of $93.44. The company’s 50 day moving average price is $60.65 and its two-hundred day moving average price is $69.12. The company has a quick ratio of 0.98, a current ratio of 0.98 and a debt-to-equity ratio of 0.23. The stock has a market cap of $5.61 billion, a P/E ratio of 10.39, a P/E/G ratio of 0.90 and a beta of 0.38.
About Amdocs
Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.
Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.
Recommended Stories
- Five stocks we like better than Amdocs
- SpaceX Has Real Value—But These 3 Stocks Have Better Odds Right Now
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.
